Consistent with the above conclusion, our study showed that ccRCC patients with low KIF21A and PIGH expression and elevated RPS6KA2 levels exhibit a poorer prognosis and overall survival than their low-risk counterparts. This evidence concerns the gene KIF21A and nonpapillary renal cell carcinoma.